| Name | Nebivolol Hydrochloride |
|---|---|
| Synonyms |
2H-1-Benzopyran-2-methanol, α,α'-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-, hydrochloride (1:1), (αR,α'R,2R,2'S)-rel
2H-1-Benzopyran-2-methanol, α,α'-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-, hydrochloride, [2R*[R*[R*(S*)]]]-(±) (±)-[2R*(1S*5S*(S*))]-α,α'-[Iminobis(methylene)bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (S,R,R,R)-nebivolol hydrochloride Nebivolol hydrochloride, beta1 antagonist a,2R,2)-rel-a,a[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] Nebivolol hydrochloride, 10 mM in DMSO a,a(Iminodimethylene)bis[6-fluoro-2-chromanmethanol] Hydrochloride NEBIVOLOL HC NEBIVOLOLHYDROCHLORIDE(SUBJECTTOPATENTFREE) Nebilox Nebivolol hydrochloride salt rel-,a′R,2R,2′S)-a,a′-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] hydrochloride D06622 Nebivolol (Bystolic) Lobivon (169-9) nebivolol hydrochloride RAC NEBIVOLOL, HYDROCHLORIDE TIANFU CHEM-Nebivolol hydrochloride Nebivolol hydrochloride (R-65824) a,a'-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol hydrochloride Nebivalate HCl NebivololHydrochloride> Nebivolol hydrochloride, >= alpha,alpha'-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol hydrochloride Nebivolol hydrochloride Impurities 2H-1-Benzopyran-2-ethanaminium, 6-fluoro-N-[(2R)-2-[(2R)-6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl]-2-hydroxyethyl]-3,4-dihydro-β-hydroxy-, chloride, (βR,2S)- (1:1) Nebivolol hydrochlorider (αR,α'R,2R,2'S)-rel-α,α'-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-Benzopyran-2-methanol hydrochloride (1:1) Nebivolol HydrochlorideQ: What is Nebivolol Hydrochloride Q: What is the CAS Number of Nebivolol Hydrochloride Q: What is the storage condition of Nebivolol Hydrochloride R-67555 Nebivolol Hcl- IP Nbivolol (S)-1-((R)-6-fluorochroman-2-yl)-2-(((S)-2-((S)-6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride R-Nebivolol D4 HCl Nebilet R 065824 hydrochloride Nebivolol hydrochloride a selective β1 antagonist Nebivolol HCl (2R)-2-[(2R)-6-Fluoro-3,4-dihydro-2H-chromen-2-yl]-N-{(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl}-2-hydroxyethanaminium chloride Nebivolol hydrochloride (usan) a,a’-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] Nebivolo Nebivolol hydrochloride in methanol Nebivolol hydrochloride //BP R 065824 hydrochloride|||Nebivolol HCl|||R-65824 (αR,α'R,2R,2'S)-rel-α,α'-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol hydrochloride Nebivolol HCl - Bio-X Nebivolol reference substance Hexamidine 2-hydroxyethansulfanonate Bystolic |
| Description | Nebivolol hydrochloride selectively inhibits β1- adrenergic receptor with IC50 of 0.8 nM.Target: β1- adrenergic receptorNebivolol reduces cell proliferation of human coronary smooth muscle cells (haCSMCs) and endothelial cells (haECs) in a concentration- and time-dependent maner. Nebivolol treatment for 7 days causes significant reduction in cell growth of haCSMCs with IC50 of 6.1 μM, and inhibits accelerated haCSMC proliferation stimulated by growth factors PDGF-BB, bFGF, and TGFβ with IC50 values of 6.8 μM, 6.4 μM and 7.7 μM, repectively. Nebivolol treatment (10-5 M) of haCSMCs for 48 hours induces a moderate apoptosis of 23% and a decrease from 16% to 5% in the number of cells in S-phase. During Nebivolol incubation, NO formation of HaCEs increases, while endothelin-1 transcription and secretion are suppressed.Administratiion of Nebivolol (initially by iv within 10 minutes of reperfusion and then orally) to rats with myocardial infarction (MI) reduces myocardial apoptosis, which is mediated by regulation of NO . Nebivolol, significantly, prevents left ventricular (LV) pressure changes, reduces total and regional apoptotic cardiomyocytes. Nebivolol treatment lowers mean blood pressure (MBP) in rats with MI slightly, but not significantly. |
|---|---|
| Related Catalog | |
| References |
| Boiling Point | 600.5ºC at 760 mmHg |
|---|---|
| Melting Point | 220-222ºC |
| Molecular Formula | C22H26ClF2NO4 |
| Molecular Weight | 441.896 |
| Flash Point | 316.9ºC |
| Exact Mass | 441.151855 |
| PSA | 70.95000 |
| LogP | 3.55650 |
| Vapour Pressure | 2.88E-15mmHg at 25°C |
| Storage condition | Desiccate at RT |
| Water Solubility | DMSO: ≥20mg/mL |
| Symbol |
GHS07, GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H410 |
| Precautionary Statements | P273-P501 |
| Hazard Codes | Xn,N |
| Risk Phrases | 22-50/53 |
| Safety Phrases | 60-61 |
| RIDADR | 3077 |
| HS Code | 2932999099 |
| HS Code | 2932999099 |
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |